newsfilter
← Latest News
GlobeNewswire·

AIM ImmunoTech to Present at the H.C. Wainwright 24th Annual Global Investment Conference

OCALA, Fla., Sept. 07, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AMERICAN) ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and vir